Yellow Fever Vaccine: all 25 studies that test it
Page 1 of 1. Open to participants first (4), then studies with results posted, then the rest; newest registration first within each.
- Non-interference Study of MR and Yellow Fever Vaccines Among Bangladeshi Infants Aged 9-12 MonthsNot yet recruitingNCT06815835Phase 3
- Antibiotics and Vaccine Immune Responses StudyRecruitingNCT06148025Phase 4
- Yellow Fever Human Infection Model With YF-17DRecruitingNCT05901454Not applicable
- Immunity to Yellow Fever in HIV-infected Patients 10 Years After a Primary Anti-yellow Fever VaccinationNot yet recruitingNCT05450770Not applicable
- Study of the Safety and Immunogenicity of Reduced Doses of the US Yellow Fever VaccineCompletedNCT05374317Phase 4Results posted
- Study on an Investigational Yellow Fever Vaccine Compared With Stamaril in Adults in Europe and AsiaActive, not recruitingNCT05011123Phase 2Results posted
- Study on an Investigational Yellow Fever Vaccine Compared With YF-VAX in Adults in the USAActive, not recruitingNCT04942210Phase 2Results posted
- The Effect of Inflammation and Damage to Lymph Node Structures on Durable Protective Immunity Following Yellow Fever VaccinationCompletedNCT04269265Phase 1/2Results posted
- Immunogenicity and Safety Study of GSK Biologicals' Candidate Malaria Vaccine Given at 6, 7.5 and 9 Months of Age in Co-administration With Measles, Rubella and Yellow Fever (YF) Vaccines Followed by a Booster of the Malaria Vaccine.CompletedNCT02699099Phase 3Results posted
- A Phase 3b, Randomized, Open-Label Study to Evaluate the Safety and Immunogenicity of Select Travel Vaccines When Administered Concomitantly With MenACWY in AdultsCompletedNCT01466387Phase 3Results posted
- Study of Yellow Fever Vaccine Administered With Tetravalent Dengue Vaccine in Healthy ToddlersCompletedNCT01436396Phase 3Results posted
- Impact of GSK Biologicals' 2189242A Vaccine on Nasopharyngeal Carriage, Safety & Immunogenicity in Children & InfantsCompletedNCT01262872Phase 2Results posted
- Study of Live Attenuated Japanese Encephalitis Vaccine (ChimeriVax™-JE) and Yellow Fever Vaccine (STAMARIL®)CompletedNCT00982137Phase 2Results posted
- Phase 3 Single Arm, Open Study on vYF in AdultsCompletedNCT07222059Phase 3
- Phase 3 Randomized, Modified Double-blind, Active-controlled Safety Study on vYF in AdultsCompletedNCT07002060Phase 3
- Infant Malaria Vaccine Schedule OptimizationActive, not recruitingNCT06879327Phase 2
- Comparison Study of SIBP's MMR Vaccine Versus GSK MMR Vaccine in Children Aged 9-11 MonthsCompletedNCT06399003Phase 3
- A Study on the Safety, Reactogenicity, and Immune Response to the GVGH iNTS-GMMA Vaccine Against Invasive Nontyphoidal Salmonella in Adults, Children, and InfantsCompletedNCT06213506Phase 2
- Cytotoxicity of Yellow Fever Specific CD8 T Cells Following YF-17D VaccinationActive, not recruitingNCT04083430Phase 4
- Yellow Fever Vaccine in Patients With Rheumatic DiseasesCompletedNCT03430388Not applicable
- Yellow Fever Vaccine on Statin/ Non Statin SubjectsCompletedNCT03116802Phase 2
- Immunity Period After One Dose of Yellow Fever Vaccine in Adults and Children (Paraiba Study)Active, not recruitingNCT02555072Phase 4
- Training Study to Characterize Biomarkers to Chickenpox and Yellow Fever VaccinesCompletedNCT01765413Not applicable
- The Yellow Fever Vaccine Immunity in HIV Infected Patients : Development of New Assays for Virological and Immunological Monitoring in HIV Infected Patient.CompletedNCT01426243Phase 3
- Turnover of Antigen Specific Lymphocytes and Monocytes After Immunization With the 17D Yellow Fever VaccineCompletedNCT01290055Phase 4